Publicacións (37) Publicacións de María Pilar Arévalo Morales

2015

  1. Predictive factors of occupational noise-induced hearing loss in Spanish workers: A prospective study

    Noise and Health, Vol. 17, Núm. 78, pp. 343-349

  2. Problemas sanitarios de los contaminantes físicos

    Medicina preventiva y salud pública (Elsevier), pp. 306-317

2011

  1. Biofilm formation by five species of Candida on three clinical materials

    Journal of Microbiological Methods, Vol. 86, Núm. 2, pp. 238-242

2008

  1. Valoración nutricional de los menús escolares de los colegios públicos de la isla de Tenerife

    Nutricion Hospitalaria, Vol. 23, Núm. 1, pp. 41-45

2006

  1. In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: Comparison of CLSI M27-A2, Sensitive YeastOne, disk diffusion, and Etest methods

    Microbial Drug Resistance, Vol. 12, Núm. 4, pp. 246-251

2005

  1. PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast

    Journal of Clinical Microbiology, Vol. 43, Núm. 12, pp. 6194-6196

  2. Salmonella enterica serotypes isolated from imported frozen chicken meat in the Canary Islands

    Journal of Food Protection, Vol. 68, Núm. 12, pp. 2702-2706

2004

  1. Comparative evaluation of four commercial tests for presumptive identification of Candida albicans

    Journal of Microbiological Methods, Vol. 59, Núm. 2, pp. 293-297

  2. Evaluation of API ID 32C® and VITEK-2® to identify Candida dubliniensis

    Diagnostic Microbiology and Infectious Disease, Vol. 50, Núm. 3, pp. 219-221

2003

  1. Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: A comparative study with M27-A microdilution method

    Journal of Antimicrobial Chemotherapy, Vol. 51, Núm. 1, pp. 163-166

  2. Performance of Bacticard™ Candida compared with the germ tube test for the presumptive identification of Candida albicans

    Mycoses, Vol. 46, Núm. 11-12, pp. 467-470

2002

  1. Antimicrobial-resistant Salmonella enterica serovars isolated from chickens in Spain

    Journal of Chemotherapy, Vol. 14, Núm. 4, pp. 346-350

  2. Comparison of Albicans ID2® agar plate with the germ tube for presumptive identification of Candida albicans

    Diagnostic Microbiology and Infectious Disease, Vol. 42, Núm. 3, pp. 181-185

2001

  1. Evaluación del medio Chromalbicans Agar para la identificación presuntiva de Candida albicans

    Revista Iberoamericana de Micologia, Vol. 18, Núm. 3, pp. 105-108

2000

  1. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole

    Chemotherapy, Vol. 46, Núm. 4, pp. 235-244

  2. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents

    Chemotherapy, Vol. 46, Núm. 6, pp. 395-401

1999

  1. Comparative study of the in vitro antifungal activity of bifonazole, naftifine and sertaconazole against yeasts

    Journal of Chemotherapy, Vol. 11, Núm. 3, pp. 187-190

  2. Determinacion mediante el sistema sensititreρ de la sensibilidad in vitro a los antifungicos de levaduras de interes medico

    Revista Espanola de Quimioterapia, Vol. 12, Núm. 2, pp. 126-135

  3. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing

    Revista Iberoamericana de Micologia, Vol. 16, Núm. 2, pp. 92-96

1996

  1. Aportaciones del comité de la AEM para la estandarización de pruebas de estudio de la sensibilidad in vitro a los antifúngicos: Método de difusión en disco

    Revista Iberoamericana de Micologia, Vol. 13, Núm. SUPPL. 2